1402602-63-4

Upstream product

• 1199556-64-3 (cis)-1-(4-bromophenyl)-3-hydroxycyclobutanecarboxylic acid 
• 1402603-53-5 3-bromo-10-fluoro-5H-benzo[e]imidazo[1,2-c][1,3]oxazine 
• 1402603-99-9 C₃₇H₂₈FN₃O₄ 
• 1402604-04-9 C₁₆H₁₁FN₂O 
• 1314936-50-9 3-fluoro-2-(1H-imidazol-2-yl)phenol 
• 1402603-29-5 10-fluoro-5H-benzo[e]imidazo[1,2-c][1,3]oxazine 
• 1199556-84-7 2-(trans-3-cyclopropyl-3-hydroxy-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclobutyl)isoindoline-1,3-dione 
• 1402603-54-6 2-bromo-10-fluoro-3-phenyl-5H-benzo[e]imidazo[1,2-c][1,3]oxazine 
• 1199557-06-6 2-(trans-1-(4-bromophenyl)-3-cyclopropyl-3-hydroxycyclobutyl)isoindoline-1,3-dione 
• 1402603-95-5 trans-3-amino-3-(4-bromophenyl)-1-cyclopropylcyclobutanol 
• 38226-10-7 2-fluoro-6-hydroxybenzaldehyde 
• 1364663-42-2 methyl 1-(4-bromophenyl)-3-oxocyclobutane-1-carboxylate 
• 1878-68-8 2-(4-bromophenyl)-acetic acid 

Relevant academic research and scientific papers

ANTITUMOR EFFECT POTENTIATOR COMPOSED OF IMIDAZOOXAZINE COMPOUND

An antitumor effect potentiator for potentiating one or more other antitumor agents, comprising, as an active ingredient, an imidazooxazine compound represented by Formula (I), or a pharmaceutically acceptable salt thereof, wherein A, B, C, and D represen

NOVEL IMIDAZO-OXAZINE COMPOUND OR SALT THEREOF

The present invention provides an imidazooxazine compound represented by Formula (I) or a salt thereof, wherein A, B, C, and D are as defined in the specification.